Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
15 févr. 2024 12h34 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective date of its ratio change of its American...
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
13 févr. 2024 09h00 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it plans to change the ratio of the American depositary shares (“ADSs”)...
Trinity Biotech to Present at Emerging Growth Conference
08 févr. 2024 08h30 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present virtually at the Emerging Growth Conference on...
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code
07 févr. 2024 08h30 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based reference laboratory, Immco Diagnostics, has applied...
Trinity Biotech Announces Q3 2023 Financial Results & Business Update
31 janv. 2024 07h05 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) today announced the Company’s results for the quarter ended September 30, 2023. Business Updates and Strategic...
Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India
31 janv. 2024 07h02 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has entered into a non-binding Letter of Intent with Bayer for the...
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
31 janv. 2024 07h00 HE
|
Trinity Biotech plc
-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management -Upfront payment of $12.5 million...
Trinity Biotech plc to Host Investor Call
30 janv. 2024 17h23 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical...
Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya
27 déc. 2023 08h57 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical...
Trinity Biotech Announces Management Changes
18 déc. 2023 16h30 HE
|
Trinity Biotech plc
John Gillard Named Chief Executive OfficerDes Fitzgerald Named Interim Chief Financial Officer DUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”),...